EUVIMEDEUVIMED entdecken
ValidierungsstudieVergleichsstudie

Development and validation of a novel reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantification of related substances of vasopressin injection: A characterization and comparative analysis of vasopressin formulation samples against vasostrict (RLD) in various diluents

Sivaji Maganti, Suryakala Duvvuri, Prudhvi Raju Pericharla, Ravi Kumar Bellam, Ameer Khan Shaik

Annales Pharmaceutiques Françaises · 2025

DOI: 10.1016/j.pharma.2025.03.007 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Annales Pharmaceutiques Françaises, 2025. Verfasst von Sivaji Maganti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GITAM Deemed to be University, Visakhapatnam, Andhra Pradesh 530045, India; Eugia Pharma Research Centre, A division of Eugi…. Hauptthemen laut MEDLINE: Chromatography, Reverse-Phase, Vasopressins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the present study, we developed and validated a sensitive, accurate, robust and simple RP-HPLC method for quantification of related substances of vasopressin (VPS) injection. The development phase prioritized the optimization of wavelength, mobile phase composition and column selection to enhance separation and sensitivity for the analytical evaluation of VPS injection. By considering peak symmetry, resolution and retention time, chromatographic conditions of VPS injection were established. The YMC PACK ODS AM (100×4.6) mm, 3μm was employed in the study. Mobile phase A was prepared with 0.113M NaH2PO4.H2O (pH 3.0) while mobile phase B was a 50:50 (v/v) ratio of acetonitrile and water, pumped through a flow rate of 1.0mL/min. VPS injection was exposed to thermal, photolytic, acid, base and peroxide degradation conditions and these were analysed by the current method. The method was validated following the guidelines set by the International Council for Harmonization guideline (ICH). The linearity studies demonstrating that a correlation coefficient value is more than 0.999 for VPS and its related substances. The detection and quantification limits for all related substances were found to be 0.01% and 0.05%, respectively. All the impurities exhibited consistent recoveries ranging from 85 to 105%. The unknown impurities were eluting at RRT 1.23 and RRT 1.25 in the RS methodology (HPLC-UV) of VPS injection are identified and assessed the impurity levels. Furthermore, aggregate profiles and secondary structure analysis studies were carried out using FTIR and LC-HRMS, comparing the VPS formulation samples with the reference listed drug (RLD) (Vasostrict) samples across various diluents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromatography, Reverse-PhaseVasopressinsChromatography, High Pressure LiquidReproducibility of ResultsDrug CompoundingChemistry, Pharmaceutical

Stichwörter der Autor:innen

Chromatographie liquide haute performance en phase inverse (RP-HPLC)Chromatographie liquide-spectrométrie de masse à haute résolution (LC-HRMS)Fourier transform infrared (FTIR) spectrometryInjection de vasopressine (VPS)International Council for Harmonization guideline (ICH)Ligne directrice du Conseil international pour l’harmonisation (ICH)Liquid chromatography-high resolution mass spectrometry (LC-HRMS)Médicament de référence (RLD)Reference listed drug (RLD)Reverse-phase high-performance liquid chromatography (RP-HPLC)Spectrométrie infrarouge à transformée de Fourier (FTIR)Vasopressin (VPS) injection

Substanzen

Vasopressins

Autor:innen und Institutionen

  • Department of Chemistry, GITAM Deemed to be University, Visakhapatnam, Andhra Pradesh 530045, India; Eugia Pharma Research Centre, A division of Eugia Pharma Specialities Limited, Pashamylaram Sangareddy (Dist.), Telang…
  • Department of Chemistry, GITAM Deemed to be University, Visakhapatnam, Andhra Pradesh 530045, India. Electronic address: sduvvuri@gitam.edu.
  • Eugia Pharma Research Centre, A division of Eugia Pharma Specialities Limited, Pashamylaram Sangareddy (Dist.), Telangana 502 307, India.
  • Eugia Pharma Research Centre, A division of Eugia Pharma Specialities Limited, Pashamylaram Sangareddy (Dist.), Telangana 502 307, India; Department of Pharmacy, Koneru Lakshmaiah Education Foundation, Green Fields, Vad…

Zitieren

APA

Maganti, S., Duvvuri, S., Pericharla, P. R., Bellam, R. K., & Shaik, A. K. (2025). Development and validation of a novel reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantification of related substances of vasopressin injection: A characterization and comparative analysis of vasopressin formulation samples against vasostrict (RLD) in various diluents. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2025.03.007

Vancouver

Maganti S, Duvvuri S, Pericharla PR, Bellam RK, Shaik AK. Development and validation of a novel reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantification of related substances of vasopressin injection: A characterization and comparative analysis of vasopressin formulation samples against vasostrict (RLD) in various diluents. Annales Pharmaceutiques Françaises. 2025. doi:10.1016/j.pharma.2025.03.007

BibTeX
@article{Maganti2025,
  author = {Maganti, Sivaji and Duvvuri, Suryakala and Pericharla, Prudhvi Raju and Bellam, Ravi Kumar and Shaik, Ameer Khan},
  title = {Development and validation of a novel reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantification of related substances of vasopressin injection: A characterization and comparative analysis of vasopressin formulation samples against vasostrict (RLD) in various diluents},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2025},
  doi = {10.1016/j.pharma.2025.03.007}
}
Kostenlos starten →